Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure
Author:
Funder
National Institute of General Medical Sciences
NIH
National Center for Advancing Translational Sciences
Publisher
Elsevier BV
Subject
Psychiatry and Mental health,Clinical Psychology
Reference36 articles.
1. Benefits of and barriers to pharmacogenomics-guided treatment for major depressive disorder;Ahmed;Clin. Pharmacol. Ther,2018
2. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene;Caspi;Science.,2003
3. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies;Connolly;Drugs,2011
4. Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial;de Montigny;J. Clinic. Psychopharmacol.,1999
5. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial;Fava;J. Clinic. Psychiat.,2001
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms;Pharmaceutical Research;2024-03-05
2. Pharmacokinetics and Pharmacodynamics: A Comprehensive Analysis of the Absorption, Distribution, Metabolism, and Excretion of Psychiatric Drugs;Pharmaceuticals;2024-02-22
3. CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression;Clinical Pharmacology & Therapeutics;2024-01-29
4. Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors;S.S. Korsakov Journal of Neurology and Psychiatry;2024
5. Antidepressant-Associated Treatment Emergent Mania;Journal of Clinical Psychopharmacology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3